Lose the weight.
Keep your life.
Four ways in, one standard of care: a licensed clinician sets and titrates your dose, medication ships cold from a certified US pharmacy, and the price on the page is the price you pay. From $139/mo.
Same standard of care. Your choice of tool.
The proven starting point — a GLP-1 receptor agonist prescribed by a licensed clinician.
Same appetite science, zero needles — a daily tablet that dissolves under the tongue.
Two appetite pathways instead of one — a dual GIP/GLP-1 receptor agonist.
Maximum-strength GLP-1 class therapy in a daily tablet. No needles, no refrigeration.
Two questions get you there.
Your clinician makes the final call in review — but this is the shape of the decision.
Needle, or no needle?+
The injections are once-weekly with a small insulin-gauge needle — most people find them a non-event after week one. If needles are the reason you'd quit or never start, take the daily tablet and lose nothing on clinical oversight.
Semaglutide, or tirzepatide?+
Semaglutide is the proven, better-priced starting point and enough for most people. Tirzepatide adds a second appetite pathway — it earns its premium when there's more weight to move, a plateau to break, or your clinician judges the dual mechanism fits your case.
What if I pick wrong?+
You can't, really. Your clinician reviews your pick against your history before anything ships, and switching format or molecule later happens inside your care plan — no starting over, no penalty.
Three steps to a plan that fits.
Choose the product and term that fit, then complete a short medical intake. Prefer to talk first? Request a call.
A provider licensed in your state reviews your file and confirms the right molecule and format — or tells you GLP-1 isn't appropriate, free.
Medication arrives from a certified US pharmacy. Your care team guides the ramp, the check-ins, and any dose adjustments.
Deals, new science, and new programs.
Join the list for member pricing, the latest research on hormones and longevity, and first access to new programs.